Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Hesai Shares Plunge Amid Strong Operational Performance

Dieter Jaworski by Dieter Jaworski
November 15, 2025
in Analysis, Automotive & E-Mobility, Earnings, Tech & Software
0
Hesai Group Stock
0
SHARES
129
VIEWS
Share on FacebookShare on Twitter

Hesai Group is experiencing a severe stock price decline that starkly contrasts with its robust operational metrics. Despite reporting record-breaking lidar deliveries and securing an exclusive major contract with Li Auto, the company’s shares have suffered dramatic losses in recent trading sessions. This divergence between fundamental strength and market performance raises important questions about investor sentiment.

Institutional Investors Show Divided Sentiment

The investment community appears deeply divided on Hesai’s prospects. Mitsubishi UFJ substantially reduced its stake by 63.3%, while other significant players including Vontobel, Acadian Asset Management, and J. Safra Sarasin aggressively expanded their positions. Institutional ownership remains substantial at 48.53%, yet the contrasting strategies highlight uncertainty about the company’s direction.

The recent exclusive lidar supply agreement for all next-generation Li Auto models represents a significant coup for Hesai. This development prompted Goldman Sachs, Morgan Stanley, and UBS to express confidence in the company’s outlook, raising their price targets to as high as $36.00.

Quarterly Results Present Mixed Picture

Hesai’s most recent quarterly report reveals both strengths and challenges. The company exceeded earnings per share expectations dramatically, reporting $0.25 compared to projections of $0.11, demonstrating operational efficiency. However, revenue of $111.70 million fell short of the $116.11 million forecast.

Other key performance indicators showed remarkable strength:
* Net revenue growth increased 47.5% year-over-year
* Lidar unit deliveries reached 441,398, representing 228.9% growth
* Gross margin remained stable at 42%
* Net income of $36.0 million has already surpassed the full-year target

Should investors sell immediately? Or is it worth buying Hesai Group?

Despite these achievements, market experts have slightly reduced their 2026 projections, potentially indicating growing caution about the company’s medium-term outlook.

Technical Indicators Signal Sustained Downtrend

Technical analysis paints a concerning picture for Hesai’s stock trajectory. Following an 8.2% decline on Friday, the downward movement continued with additional losses of 1.01%. Cumulatively, the equity has shed 17.45% of its value within just ten trading sessions.

Key technical levels show:
* Current trading price sits significantly below all major moving averages
* The 50-day average at $25.46 remains far above present levels
* The 200-day average at $22.58 confirms the persistent bearish trend

The stock now trades substantially below average analyst price targets, highlighting the disconnect between short-term market sentiment and longer-term fundamental expectations.

The central question for investors remains: when will the company’s operational achievements and strategic wins translate into share price appreciation?

Ad

Hesai Group Stock: Buy or Sell?! New Hesai Group Analysis from February 7 delivers the answer:

The latest Hesai Group figures speak for themselves: Urgent action needed for Hesai Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Hesai Group: Buy or sell? Read more here...

Tags: Hesai Group
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
Ozon Holdings PLC Stock

Ozon Shares Defy Strong Financial Performance with Market Decline

Voestalpine Stock

Voestalpine Shares Defy Economic Gravity with Strategic Shift

Silver's Rally Meets Sharp Reversal as Fed Signals Rattle Market

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com